Keyphrases
C-C Chemokine Receptor Type 5 (CCR5)
69%
Autoimmune Diabetes
66%
Macrophages
62%
Inflammatory Genes
62%
Encephalomyocarditis Virus
55%
Double-stranded RNA
55%
Virus Infection
55%
Inducible Nitric Oxide Synthase
42%
Signaling Receptor
41%
Cell Response
35%
Viral
34%
Nitric Oxide
34%
Virus Replication
31%
Cyclooxygenase-2
31%
Pancreatic Cells
31%
Antiviral Response
31%
Data Capture
27%
Systemic Juvenile Idiopathic Arthritis (sJIA)
27%
Haploinsufficiency of A20 (HA20)
27%
Lupus
27%
TNFAIP3 Gene
27%
Mitochondrial Oxidative Metabolism
27%
Type 1 Diabetes Mellitus (T1DM)
27%
Literature Management
27%
Optimal Management
27%
Viral Mimetics
27%
Inflammatory Mediators
27%
Programmed Death-ligand 1 (PD-L1)
27%
Anti-MDA5
27%
Lysis
27%
NO Synthase 2
27%
Immune Checkpoint Inhibitors
27%
Virus
27%
Type I Interferon
27%
Juvenile Dermatomyositis
27%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
27%
Mammalian Target of Rapamycin (mTOR)
27%
Aquaporin-4 (AQP4)
27%
Lateral Reading
27%
Hybrid Peptide
27%
CD4+ T Cells
27%
Chromogranin A
27%
Effector Fate
27%
Insulin
27%
Medical Students
27%
Medical Misinformation
27%
Experiential Learning
27%
Fact-checkers
27%
Antigen-specific T Cell Response
27%
T Lymphocyte Response
27%
Immunology and Microbiology
Autoimmune Diabetes
100%
Viral Disease
79%
Macrophage
62%
Encephalomyocarditis Virus
55%
Viral Replication
50%
Insulin
45%
Virus
41%
Nitric Oxide Synthase
40%
T Cell
38%
Antigen Specificity
34%
Cyclooxygenase
31%
Haploinsufficiency
27%
Lupus Erythematosus
27%
Veltuzumab
27%
Aerobic Metabolism
27%
Programmed Death 1 Ligand 1
27%
CCR5
27%
Mediator
27%
Atezolizumab
27%
Gamma Chemokine
27%
Programmed Death 1 Receptor
27%
Chemokine Receptor
27%
Diabetes Mellitus Type 1
27%
T-Helper Cell
27%
Peptides
27%
Cytokine
25%
Interferon Type I
23%
Cell Damage
18%
Programmed Cell Death
18%
Interleukin-1
17%
Gene Expression
13%
Nivolumab
13%
Host Resistance
13%
Chemokine Receptor CCR5
13%
Monoclonal Antibody
13%
Human Monoclonal Antibody
13%
Infectious Agent
13%
Cytolysis
13%
Epitope
10%
Interferon Production
9%
Proinflammatory Cytokine
9%
Antiviral Activity
9%
Immunological Method
9%
Innate Immune System
9%
Drug-Induced Lupus Erythematosus
9%
Hypogammaglobulinemia
9%
Lymphadenopathy
9%
Immunodeficiency
9%
Gene Mutation
9%
Behcet Disease
9%
